nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—Glaucoma—Donepezil—Alzheimer's disease	0.00662	0.00816	CcSEcCtD
Brimonidine—Glaucoma—Memantine—Alzheimer's disease	0.00601	0.00741	CcSEcCtD
Brimonidine—Glaucoma—Rivastigmine—Alzheimer's disease	0.00588	0.00724	CcSEcCtD
Brimonidine—Eye irritation—Donepezil—Alzheimer's disease	0.00584	0.00719	CcSEcCtD
Brimonidine—Vasodilation—Donepezil—Alzheimer's disease	0.00568	0.00699	CcSEcCtD
Brimonidine—Vasodilation procedure—Donepezil—Alzheimer's disease	0.00568	0.00699	CcSEcCtD
Brimonidine—Arthropathy—Donepezil—Alzheimer's disease	0.00549	0.00675	CcSEcCtD
Brimonidine—Stinging—Rivastigmine—Alzheimer's disease	0.00547	0.00673	CcSEcCtD
Brimonidine—Pallor—Memantine—Alzheimer's disease	0.00546	0.00673	CcSEcCtD
Brimonidine—Pallor—Rivastigmine—Alzheimer's disease	0.00534	0.00658	CcSEcCtD
Brimonidine—Apnoea—Memantine—Alzheimer's disease	0.00534	0.00658	CcSEcCtD
Brimonidine—Hypercholesterolaemia—Donepezil—Alzheimer's disease	0.00527	0.00649	CcSEcCtD
Brimonidine—Cataract—Donepezil—Alzheimer's disease	0.00524	0.00645	CcSEcCtD
Brimonidine—Apnoea—Rivastigmine—Alzheimer's disease	0.00523	0.00644	CcSEcCtD
Brimonidine—Arthropathy—Memantine—Alzheimer's disease	0.00498	0.00613	CcSEcCtD
Brimonidine—Arthropathy—Rivastigmine—Alzheimer's disease	0.00487	0.006	CcSEcCtD
Brimonidine—Arthritis—Galantamine—Alzheimer's disease	0.00481	0.00592	CcSEcCtD
Brimonidine—Hypercholesterolaemia—Memantine—Alzheimer's disease	0.00479	0.0059	CcSEcCtD
Brimonidine—Lethargy—Galantamine—Alzheimer's disease	0.00477	0.00587	CcSEcCtD
Brimonidine—Cataract—Memantine—Alzheimer's disease	0.00476	0.00586	CcSEcCtD
Brimonidine—Hypercholesterolaemia—Rivastigmine—Alzheimer's disease	0.00468	0.00577	CcSEcCtD
Brimonidine—Cataract—Rivastigmine—Alzheimer's disease	0.00465	0.00573	CcSEcCtD
Brimonidine—Respiratory failure—Memantine—Alzheimer's disease	0.00461	0.00568	CcSEcCtD
Brimonidine—Dry eye—Donepezil—Alzheimer's disease	0.00461	0.00567	CcSEcCtD
Brimonidine—Respiratory failure—Rivastigmine—Alzheimer's disease	0.00451	0.00556	CcSEcCtD
Brimonidine—Dermatitis contact—Rivastigmine—Alzheimer's disease	0.00438	0.00539	CcSEcCtD
Brimonidine—Abnormal vision—Donepezil—Alzheimer's disease	0.00435	0.00536	CcSEcCtD
Brimonidine—Diabetes mellitus—Donepezil—Alzheimer's disease	0.00416	0.00513	CcSEcCtD
Brimonidine—Coma—Memantine—Alzheimer's disease	0.00414	0.0051	CcSEcCtD
Brimonidine—Coma—Rivastigmine—Alzheimer's disease	0.00405	0.00498	CcSEcCtD
Brimonidine—Abnormal vision—Memantine—Alzheimer's disease	0.00395	0.00486	CcSEcCtD
Brimonidine—Bronchitis—Galantamine—Alzheimer's disease	0.00388	0.00478	CcSEcCtD
Brimonidine—Abnormal vision—Rivastigmine—Alzheimer's disease	0.00386	0.00476	CcSEcCtD
Brimonidine—Diabetes mellitus—Memantine—Alzheimer's disease	0.00378	0.00465	CcSEcCtD
Brimonidine—Arthritis—Donepezil—Alzheimer's disease	0.00373	0.00459	CcSEcCtD
Brimonidine—Diabetes mellitus—Rivastigmine—Alzheimer's disease	0.0037	0.00455	CcSEcCtD
Brimonidine—Eye pain—Memantine—Alzheimer's disease	0.00364	0.00448	CcSEcCtD
Brimonidine—Osteoarthritis—Donepezil—Alzheimer's disease	0.00362	0.00446	CcSEcCtD
Brimonidine—Depression—Galantamine—Alzheimer's disease	0.00359	0.00442	CcSEcCtD
Brimonidine—Eye pain—Rivastigmine—Alzheimer's disease	0.00356	0.00439	CcSEcCtD
Brimonidine—Face oedema—Donepezil—Alzheimer's disease	0.0035	0.0043	CcSEcCtD
Brimonidine—Arthritis—Memantine—Alzheimer's disease	0.00338	0.00417	CcSEcCtD
Brimonidine—Lethargy—Memantine—Alzheimer's disease	0.00335	0.00413	CcSEcCtD
Brimonidine—Dry skin—Donepezil—Alzheimer's disease	0.00332	0.00409	CcSEcCtD
Brimonidine—Arthritis—Rivastigmine—Alzheimer's disease	0.00331	0.00407	CcSEcCtD
Brimonidine—Bradycardia—Galantamine—Alzheimer's disease	0.00329	0.00405	CcSEcCtD
Brimonidine—Osteoarthritis—Memantine—Alzheimer's disease	0.00329	0.00405	CcSEcCtD
Brimonidine—Rhinitis—Galantamine—Alzheimer's disease	0.00324	0.00399	CcSEcCtD
Brimonidine—Nasopharyngitis—Donepezil—Alzheimer's disease	0.00324	0.00399	CcSEcCtD
Brimonidine—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.00322	0.00396	CcSEcCtD
Brimonidine—Influenza—Donepezil—Alzheimer's disease	0.00313	0.00385	CcSEcCtD
Brimonidine—Visual impairment—Galantamine—Alzheimer's disease	0.00311	0.00384	CcSEcCtD
Brimonidine—Face oedema—Rivastigmine—Alzheimer's disease	0.0031	0.00382	CcSEcCtD
Brimonidine—Eye disorder—Galantamine—Alzheimer's disease	0.00302	0.00372	CcSEcCtD
Brimonidine—Dry skin—Memantine—Alzheimer's disease	0.00301	0.00371	CcSEcCtD
Brimonidine—Bronchitis—Donepezil—Alzheimer's disease	0.00301	0.00371	CcSEcCtD
Brimonidine—Cardiac disorder—Galantamine—Alzheimer's disease	0.003	0.00369	CcSEcCtD
Brimonidine—Flushing—Galantamine—Alzheimer's disease	0.003	0.00369	CcSEcCtD
Brimonidine—Dry skin—Rivastigmine—Alzheimer's disease	0.00295	0.00363	CcSEcCtD
Brimonidine—Nasopharyngitis—Memantine—Alzheimer's disease	0.00294	0.00362	CcSEcCtD
Brimonidine—Angiopathy—Galantamine—Alzheimer's disease	0.00293	0.00361	CcSEcCtD
Brimonidine—Immune system disorder—Galantamine—Alzheimer's disease	0.00292	0.00359	CcSEcCtD
Brimonidine—Arrhythmia—Galantamine—Alzheimer's disease	0.00289	0.00356	CcSEcCtD
Brimonidine—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.00288	0.00354	CcSEcCtD
Brimonidine—Influenza—Memantine—Alzheimer's disease	0.00284	0.0035	CcSEcCtD
Brimonidine—Mental disorder—Galantamine—Alzheimer's disease	0.00283	0.00349	CcSEcCtD
Brimonidine—Depression—Donepezil—Alzheimer's disease	0.00278	0.00343	CcSEcCtD
Brimonidine—Dysgeusia—Galantamine—Alzheimer's disease	0.00276	0.00339	CcSEcCtD
Brimonidine—Bronchitis—Memantine—Alzheimer's disease	0.00273	0.00336	CcSEcCtD
Brimonidine—Conjunctivitis—Donepezil—Alzheimer's disease	0.00271	0.00334	CcSEcCtD
Brimonidine—Bronchitis—Rivastigmine—Alzheimer's disease	0.00267	0.00329	CcSEcCtD
Brimonidine—Vision blurred—Galantamine—Alzheimer's disease	0.00265	0.00326	CcSEcCtD
Brimonidine—Bradycardia—Donepezil—Alzheimer's disease	0.00255	0.00314	CcSEcCtD
Brimonidine—Depression—Memantine—Alzheimer's disease	0.00253	0.00311	CcSEcCtD
Brimonidine—Syncope—Galantamine—Alzheimer's disease	0.00252	0.00311	CcSEcCtD
Brimonidine—Rhinitis—Donepezil—Alzheimer's disease	0.00251	0.00309	CcSEcCtD
Brimonidine—Palpitations—Galantamine—Alzheimer's disease	0.00249	0.00306	CcSEcCtD
Brimonidine—Pharyngitis—Donepezil—Alzheimer's disease	0.00249	0.00306	CcSEcCtD
Brimonidine—Drowsiness—Rivastigmine—Alzheimer's disease	0.00248	0.00305	CcSEcCtD
Brimonidine—Loss of consciousness—Galantamine—Alzheimer's disease	0.00247	0.00304	CcSEcCtD
Brimonidine—Depression—Rivastigmine—Alzheimer's disease	0.00247	0.00304	CcSEcCtD
Brimonidine—Conjunctivitis—Memantine—Alzheimer's disease	0.00246	0.00303	CcSEcCtD
Brimonidine—Cough—Galantamine—Alzheimer's disease	0.00246	0.00302	CcSEcCtD
Brimonidine—Hypertension—Galantamine—Alzheimer's disease	0.00243	0.00299	CcSEcCtD
Brimonidine—Visual impairment—Donepezil—Alzheimer's disease	0.00241	0.00297	CcSEcCtD
Brimonidine—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00241	0.00297	CcSEcCtD
Brimonidine—Myalgia—Galantamine—Alzheimer's disease	0.0024	0.00295	CcSEcCtD
Brimonidine—Arthralgia—Galantamine—Alzheimer's disease	0.0024	0.00295	CcSEcCtD
Brimonidine—Chest pain—Galantamine—Alzheimer's disease	0.0024	0.00295	CcSEcCtD
Brimonidine—Anxiety—Galantamine—Alzheimer's disease	0.00239	0.00294	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00238	0.00293	CcSEcCtD
Brimonidine—Sinusitis—Memantine—Alzheimer's disease	0.00238	0.00293	CcSEcCtD
Brimonidine—Discomfort—Galantamine—Alzheimer's disease	0.00237	0.00291	CcSEcCtD
Brimonidine—Dry mouth—Galantamine—Alzheimer's disease	0.00234	0.00288	CcSEcCtD
Brimonidine—Sinusitis—Rivastigmine—Alzheimer's disease	0.00233	0.00286	CcSEcCtD
Brimonidine—Bradycardia—Memantine—Alzheimer's disease	0.00232	0.00285	CcSEcCtD
Brimonidine—Rhinitis—Memantine—Alzheimer's disease	0.00228	0.00281	CcSEcCtD
Brimonidine—Bradycardia—Rivastigmine—Alzheimer's disease	0.00226	0.00279	CcSEcCtD
Brimonidine—Shock—Galantamine—Alzheimer's disease	0.00226	0.00278	CcSEcCtD
Brimonidine—Pharyngitis—Memantine—Alzheimer's disease	0.00226	0.00278	CcSEcCtD
Brimonidine—Nervous system disorder—Galantamine—Alzheimer's disease	0.00225	0.00277	CcSEcCtD
Brimonidine—Tachycardia—Galantamine—Alzheimer's disease	0.00224	0.00276	CcSEcCtD
Brimonidine—Arrhythmia—Donepezil—Alzheimer's disease	0.00224	0.00276	CcSEcCtD
Brimonidine—Rhinitis—Rivastigmine—Alzheimer's disease	0.00223	0.00275	CcSEcCtD
Brimonidine—Skin disorder—Galantamine—Alzheimer's disease	0.00223	0.00275	CcSEcCtD
Brimonidine—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00221	0.00272	CcSEcCtD
Brimonidine—Mental disorder—Donepezil—Alzheimer's disease	0.00219	0.0027	CcSEcCtD
Brimonidine—Visual impairment—Memantine—Alzheimer's disease	0.00219	0.0027	CcSEcCtD
Brimonidine—Erythema—Donepezil—Alzheimer's disease	0.00218	0.00268	CcSEcCtD
Brimonidine—Hypotension—Galantamine—Alzheimer's disease	0.00215	0.00264	CcSEcCtD
Brimonidine—Visual impairment—Rivastigmine—Alzheimer's disease	0.00214	0.00264	CcSEcCtD
Brimonidine—Dysgeusia—Donepezil—Alzheimer's disease	0.00214	0.00263	CcSEcCtD
Brimonidine—Eye disorder—Memantine—Alzheimer's disease	0.00213	0.00262	CcSEcCtD
Brimonidine—Flushing—Memantine—Alzheimer's disease	0.00211	0.0026	CcSEcCtD
Brimonidine—Cardiac disorder—Memantine—Alzheimer's disease	0.00211	0.0026	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00209	0.00258	CcSEcCtD
Brimonidine—Eye disorder—Rivastigmine—Alzheimer's disease	0.00208	0.00256	CcSEcCtD
Brimonidine—Insomnia—Galantamine—Alzheimer's disease	0.00208	0.00256	CcSEcCtD
Brimonidine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00206	0.00254	CcSEcCtD
Brimonidine—Flushing—Rivastigmine—Alzheimer's disease	0.00206	0.00254	CcSEcCtD
Brimonidine—Angiopathy—Memantine—Alzheimer's disease	0.00206	0.00254	CcSEcCtD
Brimonidine—Paraesthesia—Galantamine—Alzheimer's disease	0.00206	0.00254	CcSEcCtD
Brimonidine—Vision blurred—Donepezil—Alzheimer's disease	0.00205	0.00253	CcSEcCtD
Brimonidine—Immune system disorder—Memantine—Alzheimer's disease	0.00205	0.00253	CcSEcCtD
Brimonidine—Mediastinal disorder—Memantine—Alzheimer's disease	0.00205	0.00252	CcSEcCtD
Brimonidine—Somnolence—Galantamine—Alzheimer's disease	0.00204	0.00251	CcSEcCtD
Brimonidine—Arrhythmia—Memantine—Alzheimer's disease	0.00203	0.0025	CcSEcCtD
Brimonidine—Dyspepsia—Galantamine—Alzheimer's disease	0.00202	0.00249	CcSEcCtD
Brimonidine—Angiopathy—Rivastigmine—Alzheimer's disease	0.00202	0.00249	CcSEcCtD
Brimonidine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00201	0.00247	CcSEcCtD
Brimonidine—Mental disorder—Memantine—Alzheimer's disease	0.00199	0.00245	CcSEcCtD
Brimonidine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00199	0.00245	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00198	0.00244	CcSEcCtD
Brimonidine—Fatigue—Galantamine—Alzheimer's disease	0.00198	0.00244	CcSEcCtD
Brimonidine—Syncope—Donepezil—Alzheimer's disease	0.00196	0.00241	CcSEcCtD
Brimonidine—Mental disorder—Rivastigmine—Alzheimer's disease	0.00195	0.0024	CcSEcCtD
Brimonidine—Dysgeusia—Memantine—Alzheimer's disease	0.00194	0.00239	CcSEcCtD
Brimonidine—Erythema—Rivastigmine—Alzheimer's disease	0.00194	0.00238	CcSEcCtD
Brimonidine—Loss of consciousness—Donepezil—Alzheimer's disease	0.00192	0.00236	CcSEcCtD
Brimonidine—Cough—Donepezil—Alzheimer's disease	0.0019	0.00234	CcSEcCtD
Brimonidine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.0019	0.00234	CcSEcCtD
Brimonidine—Hypertension—Donepezil—Alzheimer's disease	0.00188	0.00232	CcSEcCtD
Brimonidine—Vision blurred—Memantine—Alzheimer's disease	0.00187	0.0023	CcSEcCtD
Brimonidine—Arthralgia—Donepezil—Alzheimer's disease	0.00186	0.00229	CcSEcCtD
Brimonidine—Chest pain—Donepezil—Alzheimer's disease	0.00186	0.00229	CcSEcCtD
Brimonidine—Myalgia—Donepezil—Alzheimer's disease	0.00186	0.00229	CcSEcCtD
Brimonidine—Anxiety—Donepezil—Alzheimer's disease	0.00185	0.00228	CcSEcCtD
Brimonidine—Discomfort—Donepezil—Alzheimer's disease	0.00183	0.00226	CcSEcCtD
Brimonidine—Vision blurred—Rivastigmine—Alzheimer's disease	0.00183	0.00225	CcSEcCtD
Brimonidine—Dry mouth—Donepezil—Alzheimer's disease	0.00182	0.00224	CcSEcCtD
Brimonidine—Oedema—Donepezil—Alzheimer's disease	0.00178	0.00219	CcSEcCtD
Brimonidine—Syncope—Memantine—Alzheimer's disease	0.00178	0.00219	CcSEcCtD
Brimonidine—Infection—Donepezil—Alzheimer's disease	0.00177	0.00218	CcSEcCtD
Brimonidine—Shock—Donepezil—Alzheimer's disease	0.00175	0.00216	CcSEcCtD
Brimonidine—Palpitations—Memantine—Alzheimer's disease	0.00175	0.00215	CcSEcCtD
Brimonidine—Nervous system disorder—Donepezil—Alzheimer's disease	0.00175	0.00215	CcSEcCtD
Brimonidine—Loss of consciousness—Memantine—Alzheimer's disease	0.00174	0.00214	CcSEcCtD
Brimonidine—Syncope—Rivastigmine—Alzheimer's disease	0.00174	0.00214	CcSEcCtD
Brimonidine—Cough—Memantine—Alzheimer's disease	0.00173	0.00213	CcSEcCtD
Brimonidine—Palpitations—Rivastigmine—Alzheimer's disease	0.00171	0.00211	CcSEcCtD
Brimonidine—Hypertension—Memantine—Alzheimer's disease	0.00171	0.0021	CcSEcCtD
Brimonidine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.0017	0.0021	CcSEcCtD
Brimonidine—Hypersensitivity—Galantamine—Alzheimer's disease	0.00169	0.00208	CcSEcCtD
Brimonidine—Cough—Rivastigmine—Alzheimer's disease	0.00169	0.00208	CcSEcCtD
Brimonidine—Arthralgia—Memantine—Alzheimer's disease	0.00169	0.00208	CcSEcCtD
Brimonidine—Chest pain—Memantine—Alzheimer's disease	0.00169	0.00208	CcSEcCtD
Brimonidine—Myalgia—Memantine—Alzheimer's disease	0.00169	0.00208	CcSEcCtD
Brimonidine—Anxiety—Memantine—Alzheimer's disease	0.00168	0.00207	CcSEcCtD
Brimonidine—Hypertension—Rivastigmine—Alzheimer's disease	0.00167	0.00206	CcSEcCtD
Brimonidine—Discomfort—Memantine—Alzheimer's disease	0.00167	0.00205	CcSEcCtD
Brimonidine—Hypotension—Donepezil—Alzheimer's disease	0.00166	0.00205	CcSEcCtD
Brimonidine—Myalgia—Rivastigmine—Alzheimer's disease	0.00165	0.00203	CcSEcCtD
Brimonidine—Chest pain—Rivastigmine—Alzheimer's disease	0.00165	0.00203	CcSEcCtD
Brimonidine—Arthralgia—Rivastigmine—Alzheimer's disease	0.00165	0.00203	CcSEcCtD
Brimonidine—Dry mouth—Memantine—Alzheimer's disease	0.00165	0.00203	CcSEcCtD
Brimonidine—Asthenia—Galantamine—Alzheimer's disease	0.00165	0.00203	CcSEcCtD
Brimonidine—Anxiety—Rivastigmine—Alzheimer's disease	0.00164	0.00202	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00164	0.00202	CcSEcCtD
Brimonidine—Discomfort—Rivastigmine—Alzheimer's disease	0.00163	0.00201	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00162	0.002	CcSEcCtD
Brimonidine—Oedema—Memantine—Alzheimer's disease	0.00162	0.00199	CcSEcCtD
Brimonidine—Dry mouth—Rivastigmine—Alzheimer's disease	0.00161	0.00199	CcSEcCtD
Brimonidine—Insomnia—Donepezil—Alzheimer's disease	0.00161	0.00198	CcSEcCtD
Brimonidine—Infection—Memantine—Alzheimer's disease	0.00161	0.00198	CcSEcCtD
Brimonidine—Paraesthesia—Donepezil—Alzheimer's disease	0.0016	0.00197	CcSEcCtD
Brimonidine—Shock—Memantine—Alzheimer's disease	0.00159	0.00196	CcSEcCtD
Brimonidine—Dyspnoea—Donepezil—Alzheimer's disease	0.00159	0.00195	CcSEcCtD
Brimonidine—Nervous system disorder—Memantine—Alzheimer's disease	0.00158	0.00195	CcSEcCtD
Brimonidine—Somnolence—Donepezil—Alzheimer's disease	0.00158	0.00195	CcSEcCtD
Brimonidine—Oedema—Rivastigmine—Alzheimer's disease	0.00158	0.00195	CcSEcCtD
Brimonidine—Tachycardia—Memantine—Alzheimer's disease	0.00158	0.00194	CcSEcCtD
Brimonidine—Infection—Rivastigmine—Alzheimer's disease	0.00157	0.00193	CcSEcCtD
Brimonidine—Skin disorder—Memantine—Alzheimer's disease	0.00157	0.00193	CcSEcCtD
Brimonidine—Dyspepsia—Donepezil—Alzheimer's disease	0.00157	0.00193	CcSEcCtD
Brimonidine—Shock—Rivastigmine—Alzheimer's disease	0.00156	0.00191	CcSEcCtD
Brimonidine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00155	0.00191	CcSEcCtD
Brimonidine—Tachycardia—Rivastigmine—Alzheimer's disease	0.00154	0.0019	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00154	0.00189	CcSEcCtD
Brimonidine—Skin disorder—Rivastigmine—Alzheimer's disease	0.00154	0.00189	CcSEcCtD
Brimonidine—Fatigue—Donepezil—Alzheimer's disease	0.00153	0.00189	CcSEcCtD
Brimonidine—Pain—Donepezil—Alzheimer's disease	0.00152	0.00187	CcSEcCtD
Brimonidine—Dizziness—Galantamine—Alzheimer's disease	0.00152	0.00187	CcSEcCtD
Brimonidine—Hypotension—Memantine—Alzheimer's disease	0.00151	0.00186	CcSEcCtD
Brimonidine—Hypotension—Rivastigmine—Alzheimer's disease	0.00148	0.00182	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00147	0.00181	CcSEcCtD
Brimonidine—Insomnia—Memantine—Alzheimer's disease	0.00146	0.0018	CcSEcCtD
Brimonidine—Paraesthesia—Memantine—Alzheimer's disease	0.00145	0.00179	CcSEcCtD
Brimonidine—Rash—Galantamine—Alzheimer's disease	0.00145	0.00178	CcSEcCtD
Brimonidine—Dermatitis—Galantamine—Alzheimer's disease	0.00145	0.00178	CcSEcCtD
Brimonidine—Dyspnoea—Memantine—Alzheimer's disease	0.00144	0.00177	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00144	0.00177	CcSEcCtD
Brimonidine—Headache—Galantamine—Alzheimer's disease	0.00144	0.00177	CcSEcCtD
Brimonidine—Somnolence—Memantine—Alzheimer's disease	0.00144	0.00177	CcSEcCtD
Brimonidine—Insomnia—Rivastigmine—Alzheimer's disease	0.00143	0.00176	CcSEcCtD
Brimonidine—Dyspepsia—Memantine—Alzheimer's disease	0.00142	0.00175	CcSEcCtD
Brimonidine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00142	0.00175	CcSEcCtD
Brimonidine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00141	0.00174	CcSEcCtD
Brimonidine—Somnolence—Rivastigmine—Alzheimer's disease	0.00141	0.00173	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00139	0.00172	CcSEcCtD
Brimonidine—Fatigue—Memantine—Alzheimer's disease	0.00139	0.00172	CcSEcCtD
Brimonidine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00139	0.00171	CcSEcCtD
Brimonidine—Pain—Memantine—Alzheimer's disease	0.00138	0.0017	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00136	0.00168	CcSEcCtD
Brimonidine—Nausea—Galantamine—Alzheimer's disease	0.00136	0.00168	CcSEcCtD
Brimonidine—Fatigue—Rivastigmine—Alzheimer's disease	0.00136	0.00168	CcSEcCtD
Brimonidine—Pain—Rivastigmine—Alzheimer's disease	0.00135	0.00166	CcSEcCtD
Brimonidine—Hypersensitivity—Donepezil—Alzheimer's disease	0.00131	0.00161	CcSEcCtD
Brimonidine—Asthenia—Donepezil—Alzheimer's disease	0.00128	0.00157	CcSEcCtD
Brimonidine—Pruritus—Donepezil—Alzheimer's disease	0.00126	0.00155	CcSEcCtD
Brimonidine—Hypersensitivity—Memantine—Alzheimer's disease	0.00119	0.00147	CcSEcCtD
Brimonidine—Dizziness—Donepezil—Alzheimer's disease	0.00118	0.00145	CcSEcCtD
Brimonidine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00116	0.00143	CcSEcCtD
Brimonidine—Asthenia—Memantine—Alzheimer's disease	0.00116	0.00143	CcSEcCtD
Brimonidine—Pruritus—Memantine—Alzheimer's disease	0.00114	0.00141	CcSEcCtD
Brimonidine—Asthenia—Rivastigmine—Alzheimer's disease	0.00113	0.0014	CcSEcCtD
Brimonidine—Rash—Donepezil—Alzheimer's disease	0.00112	0.00138	CcSEcCtD
Brimonidine—Dermatitis—Donepezil—Alzheimer's disease	0.00112	0.00138	CcSEcCtD
Brimonidine—Pruritus—Rivastigmine—Alzheimer's disease	0.00112	0.00138	CcSEcCtD
Brimonidine—Headache—Donepezil—Alzheimer's disease	0.00111	0.00137	CcSEcCtD
Brimonidine—Dizziness—Memantine—Alzheimer's disease	0.00107	0.00132	CcSEcCtD
Brimonidine—Nausea—Donepezil—Alzheimer's disease	0.00106	0.0013	CcSEcCtD
Brimonidine—Dizziness—Rivastigmine—Alzheimer's disease	0.00105	0.00129	CcSEcCtD
Brimonidine—Rash—Memantine—Alzheimer's disease	0.00102	0.00125	CcSEcCtD
Brimonidine—Dermatitis—Memantine—Alzheimer's disease	0.00102	0.00125	CcSEcCtD
Brimonidine—Headache—Memantine—Alzheimer's disease	0.00101	0.00125	CcSEcCtD
Brimonidine—Rash—Rivastigmine—Alzheimer's disease	0.000997	0.00123	CcSEcCtD
Brimonidine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000996	0.00123	CcSEcCtD
Brimonidine—Headache—Rivastigmine—Alzheimer's disease	0.00099	0.00122	CcSEcCtD
Brimonidine—Nausea—Memantine—Alzheimer's disease	0.00096	0.00118	CcSEcCtD
Brimonidine—Nausea—Rivastigmine—Alzheimer's disease	0.000939	0.00116	CcSEcCtD
Brimonidine—ADRA2A—Hemostasis—F2—Alzheimer's disease	0.000101	0.000535	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—INPP5D—Alzheimer's disease	0.0001	0.000534	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR ligand binding—CCL2—Alzheimer's disease	0.0001	0.000533	CbGpPWpGaD
Brimonidine—AOX1—Disease—PTGS2—Alzheimer's disease	9.99e-05	0.000531	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—NOS2—Alzheimer's disease	9.94e-05	0.000529	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PSENEN—Alzheimer's disease	9.84e-05	0.000524	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—NOS3—Alzheimer's disease	9.83e-05	0.000523	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—GAPDH—Alzheimer's disease	9.82e-05	0.000523	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—CCR5—Alzheimer's disease	9.76e-05	0.00052	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—A2M—Alzheimer's disease	9.76e-05	0.00052	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APH1A—Alzheimer's disease	9.7e-05	0.000516	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—PRKCG—Alzheimer's disease	9.62e-05	0.000512	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—PLCB1—Alzheimer's disease	9.6e-05	0.000511	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—HTR2A—Alzheimer's disease	9.55e-05	0.000508	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ENO1—Alzheimer's disease	9.52e-05	0.000507	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PTGS1—Alzheimer's disease	9.52e-05	0.000507	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—A2M—Alzheimer's disease	9.48e-05	0.000505	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PSEN2—Alzheimer's disease	9.45e-05	0.000503	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NCSTN—Alzheimer's disease	9.44e-05	0.000503	CbGpPWpGaD
Brimonidine—ADRA2B—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	9.39e-05	0.0005	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—PRKCG—Alzheimer's disease	9.36e-05	0.000498	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CYP2D6—Alzheimer's disease	9.33e-05	0.000497	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NPY—Alzheimer's disease	9.31e-05	0.000496	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IAPP—Alzheimer's disease	9.26e-05	0.000493	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—LRP1—Alzheimer's disease	9.21e-05	0.00049	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—NOS3—Alzheimer's disease	9.14e-05	0.000487	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—CCR5—Alzheimer's disease	9.12e-05	0.000485	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—GAL—Alzheimer's disease	9e-05	0.000479	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—GFAP—Alzheimer's disease	9e-05	0.000479	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CRH—Alzheimer's disease	8.99e-05	0.000478	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—HTR2A—Alzheimer's disease	8.92e-05	0.000475	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CCR5—Alzheimer's disease	8.87e-05	0.000472	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—BCHE—Alzheimer's disease	8.85e-05	0.000471	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—IGF1—Alzheimer's disease	8.81e-05	0.000469	CbGpPWpGaD
Brimonidine—ADRA2C—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	8.77e-05	0.000467	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—PRKCG—Alzheimer's disease	8.74e-05	0.000465	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NPY—Alzheimer's disease	8.7e-05	0.000463	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—HTR2A—Alzheimer's disease	8.68e-05	0.000462	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IAPP—Alzheimer's disease	8.65e-05	0.00046	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NPS—Alzheimer's disease	8.52e-05	0.000453	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PPP3CA—Alzheimer's disease	8.48e-05	0.000451	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CRH—Alzheimer's disease	8.39e-05	0.000447	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—F2—Alzheimer's disease	8.38e-05	0.000446	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—PTGS2—Alzheimer's disease	8.36e-05	0.000445	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PTK2B—Alzheimer's disease	8.35e-05	0.000445	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PLCB1—Alzheimer's disease	8.35e-05	0.000444	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CCR5—Alzheimer's disease	8.28e-05	0.000441	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ACHE—Alzheimer's disease	8.25e-05	0.000439	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—INPP5D—Alzheimer's disease	8.15e-05	0.000434	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NTRK2—Alzheimer's disease	8.13e-05	0.000433	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—GAB2—Alzheimer's disease	8.13e-05	0.000433	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—SST—Alzheimer's disease	8.13e-05	0.000433	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—HTR2A—Alzheimer's disease	8.1e-05	0.000431	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CALM1—Alzheimer's disease	8.09e-05	0.000431	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—ABCA1—Alzheimer's disease	8.09e-05	0.000431	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—GSK3A—Alzheimer's disease	8.06e-05	0.000429	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—NOS3—Alzheimer's disease	7.99e-05	0.000425	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NPS—Alzheimer's disease	7.96e-05	0.000424	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—A2M—Alzheimer's disease	7.93e-05	0.000422	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—APP—Alzheimer's disease	7.92e-05	0.000422	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PPP3CA—Alzheimer's disease	7.92e-05	0.000421	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—F2—Alzheimer's disease	7.82e-05	0.000416	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—PRKCG—Alzheimer's disease	7.82e-05	0.000416	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PTK2B—Alzheimer's disease	7.8e-05	0.000415	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PTGS1—Alzheimer's disease	7.73e-05	0.000411	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ENO1—Alzheimer's disease	7.73e-05	0.000411	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PSEN2—Alzheimer's disease	7.68e-05	0.000409	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—F2—Alzheimer's disease	7.61e-05	0.000405	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—GAB2—Alzheimer's disease	7.59e-05	0.000404	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—SST—Alzheimer's disease	7.59e-05	0.000404	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NTRK2—Alzheimer's disease	7.59e-05	0.000404	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—VEGFA—Alzheimer's disease	7.59e-05	0.000404	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CYP2D6—Alzheimer's disease	7.58e-05	0.000403	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CALM1—Alzheimer's disease	7.56e-05	0.000402	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—GSK3A—Alzheimer's disease	7.52e-05	0.000401	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PLCB1—Alzheimer's disease	7.47e-05	0.000398	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—CCR5—Alzheimer's disease	7.41e-05	0.000394	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—APP—Alzheimer's disease	7.4e-05	0.000394	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—HTR2A—Alzheimer's disease	7.25e-05	0.000386	CbGpPWpGaD
Brimonidine—AOX1—Disease—TGFB1—Alzheimer's disease	7.22e-05	0.000384	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—BCHE—Alzheimer's disease	7.19e-05	0.000383	CbGpPWpGaD
Brimonidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	7.12e-05	0.000379	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—F2—Alzheimer's disease	7.1e-05	0.000378	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—PRKCG—Alzheimer's disease	7.1e-05	0.000378	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—VEGFA—Alzheimer's disease	7.09e-05	0.000377	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NPY—Alzheimer's disease	7.07e-05	0.000376	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IAPP—Alzheimer's disease	7.02e-05	0.000374	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PLCB1—Alzheimer's disease	6.98e-05	0.000372	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PPARGC1A—Alzheimer's disease	6.97e-05	0.000371	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NGFR—Alzheimer's disease	6.97e-05	0.000371	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—TGFB1—Alzheimer's disease	6.96e-05	0.000371	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—HMOX1—Alzheimer's disease	6.94e-05	0.00037	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CREB1—Alzheimer's disease	6.93e-05	0.000369	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CRH—Alzheimer's disease	6.82e-05	0.000363	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ADAM10—Alzheimer's disease	6.81e-05	0.000362	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PLCB1—Alzheimer's disease	6.78e-05	0.000361	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—CCL2—Alzheimer's disease	6.78e-05	0.000361	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CCR5—Alzheimer's disease	6.73e-05	0.000358	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—HTR2A—Alzheimer's disease	6.58e-05	0.00035	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—ABCA1—Alzheimer's disease	6.57e-05	0.00035	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NGFR—Alzheimer's disease	6.51e-05	0.000347	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—TGFB1—Alzheimer's disease	6.5e-05	0.000346	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CREB1—Alzheimer's disease	6.47e-05	0.000344	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NPS—Alzheimer's disease	6.46e-05	0.000344	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—S100B—Alzheimer's disease	6.44e-05	0.000343	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PPP3CA—Alzheimer's disease	6.43e-05	0.000342	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ADAM10—Alzheimer's disease	6.36e-05	0.000339	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—F2—Alzheimer's disease	6.35e-05	0.000338	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—LPL—Alzheimer's disease	6.35e-05	0.000338	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PTK2B—Alzheimer's disease	6.34e-05	0.000337	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—CCL2—Alzheimer's disease	6.33e-05	0.000337	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—GAB2—Alzheimer's disease	6.17e-05	0.000328	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NTRK2—Alzheimer's disease	6.17e-05	0.000328	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—SST—Alzheimer's disease	6.17e-05	0.000328	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CALM1—Alzheimer's disease	6.14e-05	0.000327	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IGF2—Alzheimer's disease	6.13e-05	0.000326	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—GSK3A—Alzheimer's disease	6.11e-05	0.000325	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—S100B—Alzheimer's disease	6.02e-05	0.00032	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APP—Alzheimer's disease	6.01e-05	0.00032	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IGF1R—Alzheimer's disease	5.93e-05	0.000316	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—F2—Alzheimer's disease	5.77e-05	0.000307	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—VEGFA—Alzheimer's disease	5.76e-05	0.000306	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—TP53—Alzheimer's disease	5.73e-05	0.000305	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IGF2—Alzheimer's disease	5.73e-05	0.000305	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—MTHFR—Alzheimer's disease	5.72e-05	0.000304	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—LPL—Alzheimer's disease	5.68e-05	0.000303	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PLCB1—Alzheimer's disease	5.67e-05	0.000302	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PPARGC1A—Alzheimer's disease	5.66e-05	0.000302	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—HMOX1—Alzheimer's disease	5.64e-05	0.0003	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MEF2C—Alzheimer's disease	5.63e-05	0.0003	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IGF1R—Alzheimer's disease	5.54e-05	0.000295	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—PRKCG—Alzheimer's disease	5.53e-05	0.000294	CbGpPWpGaD
Brimonidine—AOX1—Disease—IL6—Alzheimer's disease	5.44e-05	0.00029	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NGF—Alzheimer's disease	5.38e-05	0.000287	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—TP53—Alzheimer's disease	5.35e-05	0.000285	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CALM1—Alzheimer's disease	5.34e-05	0.000284	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—APOE—Alzheimer's disease	5.32e-05	0.000283	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—LPL—Alzheimer's disease	5.31e-05	0.000283	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NGFR—Alzheimer's disease	5.29e-05	0.000282	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—TGFB1—Alzheimer's disease	5.28e-05	0.000281	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—CAV1—Alzheimer's disease	5.27e-05	0.000281	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MEF2C—Alzheimer's disease	5.26e-05	0.00028	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CREB1—Alzheimer's disease	5.26e-05	0.00028	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCR5—Alzheimer's disease	5.24e-05	0.000279	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ADAM10—Alzheimer's disease	5.17e-05	0.000275	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—PRKCG—Alzheimer's disease	5.16e-05	0.000275	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—LPL—Alzheimer's disease	5.16e-05	0.000275	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—CCL2—Alzheimer's disease	5.14e-05	0.000274	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—HTR2A—Alzheimer's disease	5.12e-05	0.000273	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NGF—Alzheimer's disease	5.03e-05	0.000268	CbGpPWpGaD
Brimonidine—AOX1—Disease—AKT1—Alzheimer's disease	5.02e-05	0.000267	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCR5—Alzheimer's disease	4.89e-05	0.00026	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—S100B—Alzheimer's disease	4.89e-05	0.00026	CbGpPWpGaD
Brimonidine—ADRA2B—Hemostasis—AKT1—Alzheimer's disease	4.84e-05	0.000258	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—HTR2A—Alzheimer's disease	4.79e-05	0.000255	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CALM1—Alzheimer's disease	4.78e-05	0.000254	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—LEP—Alzheimer's disease	4.76e-05	0.000254	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—APOE—Alzheimer's disease	4.76e-05	0.000254	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CAV1—Alzheimer's disease	4.72e-05	0.000251	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IGF2—Alzheimer's disease	4.65e-05	0.000248	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—MTHFR—Alzheimer's disease	4.64e-05	0.000247	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PPARG—Alzheimer's disease	4.64e-05	0.000247	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—ESR1—Alzheimer's disease	4.55e-05	0.000242	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—INS—Alzheimer's disease	4.55e-05	0.000242	CbGpPWpGaD
Brimonidine—ADRA2C—Hemostasis—AKT1—Alzheimer's disease	4.52e-05	0.000241	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IGF1R—Alzheimer's disease	4.5e-05	0.000239	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—F2—Alzheimer's disease	4.49e-05	0.000239	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CALM1—Alzheimer's disease	4.47e-05	0.000238	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—APOE—Alzheimer's disease	4.45e-05	0.000237	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—LEP—Alzheimer's disease	4.45e-05	0.000237	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CAV1—Alzheimer's disease	4.41e-05	0.000235	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NOTCH1—Alzheimer's disease	4.4e-05	0.000234	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—TP53—Alzheimer's disease	4.35e-05	0.000231	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CALM1—Alzheimer's disease	4.34e-05	0.000231	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—APOE—Alzheimer's disease	4.32e-05	0.00023	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—LPL—Alzheimer's disease	4.31e-05	0.00023	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—CAV1—Alzheimer's disease	4.28e-05	0.000228	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MEF2C—Alzheimer's disease	4.27e-05	0.000227	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—ESR1—Alzheimer's disease	4.25e-05	0.000226	CbGpPWpGaD
Brimonidine—AOX1—Metabolism—AKT1—Alzheimer's disease	4.2e-05	0.000224	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—F2—Alzheimer's disease	4.2e-05	0.000223	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—PRKCG—Alzheimer's disease	4.19e-05	0.000223	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—GSK3B—Alzheimer's disease	4.13e-05	0.00022	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NOTCH1—Alzheimer's disease	4.11e-05	0.000219	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CREB1—Alzheimer's disease	4.09e-05	0.000218	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	4.08e-05	0.000217	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—INS—Alzheimer's disease	4.07e-05	0.000217	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CCL2—Alzheimer's disease	4e-05	0.000213	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—NOS3—Alzheimer's disease	3.99e-05	0.000212	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	3.97e-05	0.000211	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IGF1—Alzheimer's disease	3.94e-05	0.00021	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	3.89e-05	0.000207	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—GSK3B—Alzheimer's disease	3.85e-05	0.000205	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CREB1—Alzheimer's disease	3.82e-05	0.000203	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—INS—Alzheimer's disease	3.8e-05	0.000202	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PPARG—Alzheimer's disease	3.77e-05	0.0002	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CCL2—Alzheimer's disease	3.74e-05	0.000199	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—INS—Alzheimer's disease	3.69e-05	0.000197	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IGF1—Alzheimer's disease	3.68e-05	0.000196	CbGpPWpGaD
Brimonidine—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	3.67e-05	0.000195	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—PTGS2—Alzheimer's disease	3.65e-05	0.000194	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	3.63e-05	0.000193	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	3.61e-05	0.000192	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	3.61e-05	0.000192	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	3.58e-05	0.000191	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	3.57e-05	0.00019	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	3.45e-05	0.000184	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	3.41e-05	0.000181	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.34e-05	0.000178	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	3.33e-05	0.000177	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	3.24e-05	0.000172	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	3.13e-05	0.000167	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	3.11e-05	0.000165	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	3.09e-05	0.000164	CbGpPWpGaD
Brimonidine—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	3.06e-05	0.000163	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	3.04e-05	0.000162	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	3.03e-05	0.000161	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	3.01e-05	0.00016	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	2.99e-05	0.000159	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	2.96e-05	0.000158	CbGpPWpGaD
Brimonidine—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	2.86e-05	0.000152	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	2.83e-05	0.000151	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	2.81e-05	0.00015	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	2.79e-05	0.000148	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	2.78e-05	0.000148	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	2.71e-05	0.000144	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	2.6e-05	0.000138	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	2.59e-05	0.000138	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	2.57e-05	0.000137	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.4e-05	0.000128	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	2.36e-05	0.000126	CbGpPWpGaD
Brimonidine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.32e-05	0.000124	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	2.3e-05	0.000122	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	2.28e-05	0.000122	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.2e-05	0.000117	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.11e-05	0.000112	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.11e-05	0.000112	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.95e-05	0.000104	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	1.94e-05	0.000103	CbGpPWpGaD
Brimonidine—ADRA2C—Metabolism—AKT1—Alzheimer's disease	1.83e-05	9.76e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	1.81e-05	9.66e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.79e-05	9.53e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	1.78e-05	9.47e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	1.66e-05	8.84e-05	CbGpPWpGaD
Brimonidine—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	1.64e-05	8.73e-05	CbGpPWpGaD
Brimonidine—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	1.53e-05	8.16e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	1.49e-05	7.92e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	1.47e-05	7.85e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	1.35e-05	7.18e-05	CbGpPWpGaD
Brimonidine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.24e-05	6.63e-05	CbGpPWpGaD
